ASX Announcements

Living Cell Technologies' Chief Operating Officer, Dr Belinda Di Bartolo, presented an update on LCT's third clinical trial of NTCELL in Parkinson's disease at the Gold Coast Investment Showcase conference.

Living Cell Technologies invites investors to attend the Gold Coast Investment Showcase, to be held from 22-23 June at JW Marriott Gold Coast Resort & Spa, Qld. LCT's COO, Dr Belinda Di Bartolo, will provide an investor update from 3.30pm AEST Wednesday.

Change of Director's Interest Notice for Non-Executive Director, Professor Carolyn Sue.

Change of Director's Interest Notice for Non-Executive Director, Mr Robert Willcocks.

Application for the quotation of 257,000,000 LCT securities, issued as part of a placement.